In Vivo CAR T Cell Therapy (ModeX Therapeutics)

N/A

Report date: 2025/04/11 11:30:47

Base Information

Drug NameIn Vivo CAR T Cell Therapy (ModeX Therapeutics)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsAutoimmune DiseasesLymphoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesModeX Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesModeX Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsAutoimmune DiseasesLymphoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A